An Impedance Sensor for Pathologically Relevant Detection of In-Stent Restenosis In Vitro.

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Medical Device Technology

Background:

• Cardiovascular disease (CVD) is a leading global cause of death, often caused by atherosclerosis and leading to heart attacks and strokes.
• Implantable stents are used to treat blocked arteries, but can become re-blocked by intimal hyperplasia, characterized by smooth muscle cell proliferation.
• Early detection of intimal hyperplasia is crucial for preventing stent complications and improving patient outcomes.

Purpose of the Study:

• To develop and validate a novel sensor system for early detection of intimal hyperplasia within stented arteries.
• To utilize electrical impedance spectroscopy (EIS) to monitor cellular changes indicative of stent re-blocking.
• To create a potential early warning system for clinicians to manage stent-related complications.

Main Methods:

• Fabrication of platinum interdigitated electrodes on silicon sensor wafers.
• Co-culture of varying ratios of mouse smooth muscle cells and endothelial cells on the sensors to mimic in vivo stent environment.
• Characterization of cell impedance trends using detection frequency and calculating 'Peak Cumulative Gradients' (PCG) over time.

Main Results:

• Successful co-culture of smooth muscle cells and endothelial cells on EIS sensors.
• Development and application of PCG metric to differentiate between cell types.
• Demonstrated ability of PCG to successfully discriminate between different cell populations.

Conclusions:

• EIS-based sensors with PCG analysis show promise for detecting intimal hyperplasia.
• This technology can serve as an early warning system for stent re-blocking.
• The developed sensor system has the potential to guide clinical decision-making and reduce stent complications.